EYE Stock Recent News

National Vision Holdings Inc (NASDAQ:EYE ) Q4 2024 Earnings Conference Call February 26, 2025 8:00 AM ET Company Participants Tamara Gonzalez - VP of Investor Relations Reade Fahs - CEO Alex Wilkes - President Melissa Rasmussen - CFO Conference Call Participants Michael Lasser - UBS Anthony Chukumba - Loop Capital Markets Taylor Brimberg - Wells Fargo Simeon Gutman - Morgan Stanley Meghan Holtz - Jefferies Adrienne Yih - Barclays Molly Baum - Bank of America Operator Good day, and thank you for standing by. Welcome to the Fourth Quarter 2024 National Vision Holdings Earnings Conference Call.

National Vision (EYE) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.02 per share a year ago.

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the fourth quarter and fiscal year ended December 28, 2024, and is providing its outlook for fiscal 2025. “Fiscal 2024 was an important year for National Vision as we took decisive steps to strengthen our foundation and accelerate our transformation,” said Reade Fahs, National Vision's CEO. “We began implementing meaningful change throughout th.

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced the appointment of Christopher Laden as Chief Financial Officer, effective March 31, 2025. He will succeed Melissa Rasmussen who, as previously announced, will step down from the Company, effective March 3, 2025. “We are thrilled to welcome Chris to National Vision. He has a proven track record of successfully developing finance organizations into strong cross-function.

National Vision continues to draw investors' attention with its strategic transformation efforts, while positive industry trends should favor its growth.

DULUTH, Ga.--(BUSINESS WIRE)--National Vision, Inc. announced today that its charitable foundation, 20/20 Quest, has awarded a $25,000 grant to Optometry Giving Sight (OGS). The funding supports OGS's ongoing mission to combat preventable blindness and vision impairment by expanding access to optometry professionals in underserved regions. Since its inception, OGS has awarded over 200 grants, provided eye care to more than 8 million people, and trained over 14,000 optometrists and eye care prof.

Investors should keep a tab on stocks like General Motors, Dana, Valero Energy, National Vision and Avis Budget for high returns.

National Vision (EYE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

National Vision (EYE) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of National Vision (EYE) and Clorox (CLX). But which of these two stocks is more attractive to value investors?